prof. dr. M.J. (Maarten) Postma

Professor Dept of Pharmacy & 2ndary appointment Professor UMCG

prof. dr. M.J. (Maarten) Postma


  1. 2015
  2. Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P., Marshall, D. A., Nord, E., ... Toumi, M. (2015). Interventions for Ultra-Rare Disorders (URDs) and the logic of cost effectiveness. Value in Health, 18(3), 6.
  3. Pitman, J. P., Wilkinson, R., Liu, Y., von Finckenstein, B., Smit Sibinga, C. T., Lowrance, D. W., ... Basavaraju, S. V. (2015). Blood Component Use in a Sub-Saharan African Country: Results of a 4-Year Evaluation of Diagnoses Associated With Transfusion Orders in Namibia. Transfusion medicine reviews, 29(1), 45-51.
  4. Mafirakureva, N., Khoza, S., Hassall, O., Faragher, B. E., Kajja, I., Mvere, D. A., ... van Hulst, M. (2015). Profiles of blood and blood component transfusion recipients in Zimbabwe. Blood transfusion, 13(4), 600-609.
  5. 2014
  6. Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P. L., Nord, E., Persson, U., ... Toumi, M. (2014). The evaluation of economic methods to assess the social value of medical interventions for ultra-rare disorders (URDs). Value in Health, 17(7), A324.
  7. Van Boven, J., Tommelein, E., Mehuys, E., Boussery, K., Vegter, S., Brusselle, G., ... Postma, M. (2014). Therapietrouwbevordering COPD bespaart kosten. Pharmaceutisch Weekblad, 149(39), 20-21.
  8. Bergmeijer, T. O., Janssen, P. W. A., Asselbergs, F. W., Schipper, J. C., Van 'T Hof, A. W., Dewilde, W. J. M., ... Ten Berg, J. M. (2014). A tailored antiplatelet strategy in STEMI patients based on CYP2C19 genotyping is feasible in daily practice-POPular Genetics study. European Heart Journal, 35, 191-192.
  9. Mafirakureva, N., Nyoni, H., Chikwereti, R., Khoza, S., Mvere, D. A., Emmanuel, J. C., ... Van Hulst, M. (2014). The average unit production cost of blood in Zimbabwe from a provider's perspective. Transfusion, 54.
Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 193217